This inventor holds 4 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Hoffmann-La Roche Inc., Roche Glycart Ag. Active years: 2015-2022.
Location History:
- Munich, DE (2015 - 2018)
- Germering, DE (2022)
Company Filing History:
Years Active: 2015-2022
Title: The Innovative Contributions of Katharina Wartha in Cancer Treatment
Introduction
Katharina Wartha is a notable inventor based in Munich, Germany, known for her significant contributions to the field of cancer treatment. With a remarkable portfolio of four patents, her work primarily focuses on innovative approaches to combating colon cancer through the development of novel antibody therapies.
Latest Patents
Wartha's latest patents highlight her dedication to advancing cancer therapies. One of her pivotal inventions involves methods for treating colon cancer or inhibiting cell proliferation by administering a combination of antibodies against human CSF-1R and antibodies against human PD-L1. This combination therapy presents a promising approach for enhancing the efficacy of immunotherapy in cancer patients. Another notable patent pertains to bispecific antibodies, covering methods for their production, pharmaceutical compositions containing these antibodies, and potential uses in therapeutic settings.
Career Highlights
Throughout her career, Katharina Wartha has made significant strides while working with prominent companies such as Hoffmann-La Roche Inc. and Roche Glycart AG. Her expertise and innovative spirit have helped to shape the methodologies behind modern cancer treatments.
Collaborations
Wartha's collaborations with esteemed professionals, including Sabine Hoves and Carola Ries, have further fueled her research and development efforts. These partnerships have been instrumental in driving forward her innovative concepts and bringing them closer to real-world applications in healthcare.
Conclusion
Katharina Wartha's contributions to cancer treatment demonstrate her commitment to innovation and life-saving research. Her work with bispecific antibodies and combination therapies stands at the forefront of medical advancements, promising hope for many patients facing cancer diagnoses in the future.